| ASC42 had a favorable safety, and pharmacokinetic/pharmacodynamic profiles for further investigation. No pruritus was reported at therapeutic dose range (5–15 mg) of ASC42 in healthy subjects. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.